LexDanaLexDanabeta
Inventor

Tao Li

Inventor
Grayslake, IL, US

Overview

50→
Patents
1998–2020
Patent span
Chemistry
Primary field (CPC C)

Patents· 50 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations20%
C07DHeterocyclic compounds18%
C12NMicroorganisms or enzymes14%
A61KPreparations for medical, dental or toiletry purposes11%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms8%
C12YEnzymes5%
C07CAcyclic or carbocyclic compounds3%
G01NInvestigating or analysing materials by determining their chemical or physical properties3%
Y02PClimate change mitigation technologies in the production or processing of goods3%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture2%
PatentTitleYear
10,786,481Hydroquinone compounds, preparation methods therefor, and use in anti-tumor or immunomodulation therapy202010,731,189Engineered proline hydroxylase polynucleotides and methods202010,486,139IrO201910,370,688Methods for hydroxylyation of chemical compounds20199,983,218Indole and indoline derivatives and methods of use thereof20189,845,457Maintenance of genomic stability in cultured stem cells20179,828,588Methods and compositions for producing active vitamin K-dependent proteins20179,790,527'Engineered proline hydroxylase polypeptides'20179,625,475'Indole and indoline derivatives and methods of use thereof'20179,441,208'Methods and compositions for producing vitamin K dependent proteins'20169,249,392'Methods and compositions for maintaining genomic stability in cultured stem cells'20169,186,407'Pharmaceutical compositions and their methods of use'20159,063,126'Indole and indoline derivatives and methods of use thereof'20159,040,568'Pharmaceutical compositions for the treatment of pain'20158,987,453'Azaadamantane derivatives and methods of use'20158,853,241'Biaryl substituted azabicyclic alkane derivatives'20148,778,959'AZA-bridged ring-fused indoles and indolines'20148,771,404'Hollow ceramic fibers, precursors for manufacture thereof utilizing nanoparticles, methods of making the same, and methods of using the same'20148,747,525'Composite hollow ceramic fibers, precursors for, methods of making the same, and methods of using the same'20148,669,255'Substituted octahydropyrrolo[1,2-a]pyrazines as calcium channel blockers'20148,648,074'Substituted octahydropyrrolo[1,2-a]pyrazine sulfonamides as calcium channel blockers'20148,603,823'Methods and compositions for producing vitamin K dependent proteins'20138,524,703'Bridgehead amine ring-fused indoles and indolines'20138,486,979'1,2,4 oxadiazole compounds and methods of use thereof'20138,426,128'Methods and compositions for vitamin K epoxide reductase'20138,383,658'Isoxazole based neuronal nicotinic receptor ligands and methods of use'20138,314,119'Azaadamantane derivatives and methods of use'20128,163,916'Azaadamantane ester and carbamate derivatives and methods of use thereof'20128,097,410'Methods and compositions for vitamin K epoxide reductase'20128,076,350'Spirocyclic azaadamantane derivatives and methods of use'20117,951,791'Amino-substituted tricyclic derivatives and methods of use'20117,902,222'Biaryl substituted azabicyclic alkane derivatives'20117,872,017'Fused bicycloheterocycle substituted azabicyclic alkane derivatives'20117,872,010'Substituted diazabicycloalkane derivatives having affinity for nicotinic acetylcholine receptors'20117,858,318'Methods and compositions for vitamin K epoxide reductase'20107,687,233'Methods and compositions for the correlation of single nucleotide polymorphisms in the vitamin K epoxide reductase gene and warfarin dosage'20107,674,794'Fused bicycloheterocycle substituted quinuclidine derivatives'20107,645,602'Methods and compositions for producing vitamin K dependent proteins'20107,524,665'Methods and compositions for vitamin K epoxide reductase'20097,482,141'Methods and compositions for vitamin K epoxide reductase'20097,425,433'Carboxylic acid reductase polypeptide, nucleotide sequence encoding same and methods of use'20087,399,765'Substituted diazabicycloalkane derivatives'20087,365,193'Amino-substituted tricyclic derivatives and methods of use'20087,309,699'3-Quinuclidinyl amino-substituted biaryl derivatives'20077,241,773'3-quinuclidinyl heteroatom bridged biaryl derivatives'20077,160,876'Fused bicycloheterocycle substituted quinuclidine derivatives'20077,056,714'Carboxylic acid reductase polypeptide, nucleotide sequence encoding same and methods of use'20067,045,530'Spirocyclic quinuclidinic ether derivatives'20066,261,814'Carboxylic acid reductase, and methods of using same'20015,795,759'Carboxylic acid reductase, and methods of using same'1998

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2006–2013Patents assigned to ABBOTT LAB (14)· patent assignee history
2006–2018Based in Grayslake, IL, US· patent location history
2009–2017Based in San Diego, CA, US· patent location history
2011–2017Patents assigned to LI TAO (17)· patent assignee history
2011–2017Patents assigned to LEE CHIH-HUNG (11)· patent assignee history
2011–2017Patents assigned to SIPPY KEVIN B (10)· patent assignee history
2012–2018Patents assigned to ABBVIE INC (13)· patent assignee history
2014Based in Garnet Valley, PA, US· patent location history
2016–2017Based in Nanchang, CN· patent location history
2017–2020Based in Cincinnati, OH, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
LI TAOself172011–2017
ABBOTT LAB142006–2013
ABBVIE INC132012–2018
LEE CHIH-HUNG112011–2017
SIPPY KEVIN B102011–2017
Locations
LocationPatentsSpan
Grayslake, Illinois, US272006–2018
San Diego, California, US102009–2017
Cincinnati, OH, US32017–2020
Nanchang, CN22016–2017
Garnet Valley, Pennsylvania, US22014